EV/EBITDA
-6.11
0.000.00%
84 min ago
Summary
- As of February 25, 2025, SYRE EV/EBITDA is -6.11, unchanged from the previous trading day.
- Over the past year, SYRE EV/EBITDA has dropped by -0.91 (-17.50%).
- SYRE EV/EBITDA is now -328.84% below its all-time high of 2.67.
Performance
SYRE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SYRE EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | 0.0% | 0.0% | 0.0% |
| 1 m1 month | +4.1% | -4.1% | -3.8% |
| 3 m3 months | +21.3% | -21.3% | -20.3% |
| 6 m6 months | +17.9% | -7.3% | -17.8% |
| ytdytd | +5.1% | -5.1% | -4.9% |
| 1 y1 year | -17.5% | +79.6% | -8.7% |
| 5 y5 years | -149.4% | +508.7% | -88.1% |
SYRE EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -4.4% | -6.86 | +10.9% | |
| 3 m | 3-month | -5.80 | -5.3% | -8.41 | +27.4% |
| 6 m | 6-month | -5.80 | -5.3% | -10.47 | +41.6% |
| 1 y | 1-year | -2.74 | -123.0% | -11.80 | +48.2% |
| 3 y | 3-year | 2.67 | -328.8% | -11.80 | +48.2% |
| 5 y | 5-year | 2.67 | -328.8% | -11.80 | +48.2% |
| alltime | all time | 2.67 | -328.8% | -11.80 | +48.2% |
Spyre Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -6.11(-5.1%) |
| 2024 | -6.44(+40.0%) |
| 2023 | -4.60(<-9900.0%) |
| 2022 | 0.01(-100.3%) |
| 2021 | -3.50(-3.8%) |
| Date | Value |
|---|---|
| 2020 | -3.64(+40.0%) |
| 2019 | -2.60(-25.9%) |
| 2018 | -3.51(+24.5%) |
| 2017 | -2.82(+475.5%) |
| 2016 | -0.49 |
FAQ
- What is Spyre Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Spyre Therapeutics?
- What is SYRE EV/EBITDA year-to-date change?
- What is Spyre Therapeutics EV/EBITDA year-on-year change?
What is Spyre Therapeutics EV/EBITDA?
The current EV/EBITDA of SYRE is -6.11
What is the all time high EV/EBITDA for Spyre Therapeutics?
Spyre Therapeutics all-time high EV/EBITDA is 2.67
What is SYRE EV/EBITDA year-to-date change?
Spyre Therapeutics EV/EBITDA has changed by +0.33 (+5.12%) since the beginning of the year
What is Spyre Therapeutics EV/EBITDA year-on-year change?
Over the past year, SYRE EV/EBITDA has changed by -0.91 (-17.50%)